April 29 (Reuters) - U.S. drugmaker Pfizer ( PFE )
reported first-quarter revenue below Wall Street estimates on
Tuesday, hurt by a decline in sales of its COVID antiviral
treatment, Paxlovid.
It reported total revenue of $13.70 billion for the first
quarter, compared with analysts' expectations of $13.91 billion,
according to LSEG data.